Cadre Bioscience Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Cadre Bioscience General Information

Description

Developer of a portfolio intended for novel therapeutics of human disease. The company's therapeutics for human diseases of high unmet medical need, is enabling businesses to launch their technology down a commercialization path for market access and patient benefit.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Practice Management (Healthcare)
Primary Office
  • 4340 Duncan Avenue
  • Suite 239
  • Saint Louis, MO 63110
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cadre Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 15-Jan-2020 Completed Startup
To view Cadre Bioscience’s complete valuation and funding history, request access »

Cadre Bioscience Executive Team (3)

Name Title Board Seat Contact Info
Bob Karr MD Chief Executive Officer and Executive Chairman
Eric Miller Ph.D Chief Operating Officer
Michael Tones Ph.D Chief Scientific Officer
To view Cadre Bioscience’s complete executive team members history, request access »

Cadre Bioscience Board Members (1)

Name Representing Role Since
Bob Karr MD Cadre Bioscience Chief Executive Officer and Executive Chairman 000 0000
To view Cadre Bioscience’s complete board members history, request access »

Cadre Bioscience Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioGenerator Venture Capital Minority 000 0000 000000 0
To view Cadre Bioscience’s complete investors history, request access »